For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Aurobindo Pharma gains 10% in three days on USFDA approval

|

 Aurobindo Pharma gains 10% in three days on USFDA approval
Aurobindo Pharma: Quotes, News
BSE 916.50BSE Quote8.3 (0.91%)
NSE 916.60NSE Quote8.35 (0.91%)
Shares of Aurobindo Pharma jumped once again on Monday by 2%, gaining almost 10% in three trading sessions. The shares were last trading at Rs 130.75 on the Bombay Stock Exchange.

Aurobindo Pharma has been rising ever since the company secured final approval from the USFDA to manufacture & market Amlodipine Besylate and Benazepril Hydrochloride Capsules.

 

The company is an integrated pharma company, which features among the top 10 companies in India in terms of consolidated revenues.
Aurobindo exports to over 125 countries across the globe with more than 70% of its revenues derived out of international operations.

GoodReturns.in

Read more about: aurobindo pharma
Company Search
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X